NCT04749017 (SMOK) is a NA clinical trial of Experimental product consumption in Smoking Reduction, sponsored by Universidad Católica San Antonio de Murcia.

Who is sponsoring NCT04749017?

NCT04749017 is sponsored by Universidad Católica San Antonio de Murcia.

What drugs are being tested in NCT04749017?

Interventions in NCT04749017: Experimental product consumption, Control product consumption.

What condition does NCT04749017 study?

NCT04749017 studies Smoking Reduction.

Is NCT04749017 still recruiting?

NCT04749017 is currently completed. Last updated 15 February 2022.

Last reviewed 2022-02-15 · How we verify

NCT04749017: SMOK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience

Completed NA Last updated 15 February 2022

What this trial tests

NA trial testing Experimental product consumption in Smoking Reduction in 140 participants. Completed in 31 December 2021.

Timeline

20 January 2021

Primary endpoint
30 July 2021

31 December 2021

Quick facts

Lead sponsor	Universidad Católica San Antonio de Murcia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	140
Start date	20 January 2021
Primary completion	30 July 2021
Estimated completion	31 December 2021
Sites	1 location across Spain

Drugs / interventions tested

Experimental product consumption
Control product consumption

Conditions studied

Smoking Reduction — all drugs for Smoking Reduction →

Sponsor

Universidad Católica San Antonio de Murcia

Who can join

Adults 18 to 65, any sex, with Smoking Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the potential effect of Avena Sativa L. on wellbeing during smoking reduction/cessation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Dietary supplementation with a wild green oat extract (<i>Avena sativa</i> L.) to improve wellness and wellbeing during smoking reduction or cessation: a randomized double-blind controlled study.
Friling M, García-Muñoz AM, Lavie A, Pérez-Piñero S, et al · · 2024 · PMID 38962436 · DOI 10.3389/fnut.2024.1405156

Verify or expand the search:

Other trials of Experimental product consumption

Trials testing the same drug.

NCT04199234 — A Study to Compare the Tolerability of Microencapsulated Iron Compared to a Conventional Iron Supplement in the Market · NA · completed

Other recruiting trials for Smoking Reduction

Currently open trials in the same condition.

NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
NCT06693700 — A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · NA · recruiting
NCT06675526 — Detour: a Smartphone Game to Help Youth Quit Smoking · NA · recruiting
NCT06458205 — Impact of Multi-Component Interventions on High-Risk COPD Smokers · NA · active not recruiting
NCT06311162 — Early Life Intervention in Pediatrics Supported by E-health - SMOKE · NA · recruiting

Other Universidad Católica San Antonio de Murcia trials

Trials by the same sponsor.

NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
NCT07519980 — Xanthigen and Its Impact on Weight and Metabolic Health · NA · recruiting
NCT07391189 — Healthy Effects of Adapted Aikido in People With Grip Disfunction · NA · recruiting
NCT07379931 — Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes · NA · not yet recruiting
NCT07488000 — Plyometric Exercises During the Winter Pre-season in Sprinters · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04749017 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Católica San Antonio de Murcia
Last refreshed: 15 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing